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Background: Total nasal symptom score is widely used to evaluate the severity of allergic rhinitis, but the
clinical signiﬁcance of extranasal symptoms is largely unknown. We wished to analyze the presenting
symptoms in allergic rhinitis, as well as their relationship with quality of life (QoL) and therapeutic
outcomes.
Methods: Presenting symptoms and QoL were assessed using the OptumTM SF-12v2® Health Survey in
260 patients with allergic rhinitis. Clinical response at 3 months after treatment was measured.
Results: Ten most common symptoms presenting with at least moderate severity in allergic rhinitis
were: blocked nose (82.7%), rhinorrhea (75.0%), sneeze (70.9%), itchy nose (68.5%), fatigue (63.6%), mouth
breathing (61.1%), daytime somnolence (52.7%), postnasal drip (49.1%), itchy eyes (47.3%), and dry mouth
(46.3%). Severity of sneeze was correlated with physical component summary (PCS) whereas postnasal
drip and daytime somnolence were correlated with mental component summary (MCS). Severity of dry
mouth was correlated with PCS and MCS. The symptoms with the highest severity scores after treatment
were blocked nose, postnasal drip, fatigue, and dry mouth, respectively.
Conclusions: Extranasal symptom scores correlated well with physical health and mental health in
allergic rhinitis patients. Assessment of extranasal symptoms should be included to evaluate disease
severity and assess therapeutic outcomes. Clinical trial NCT02000648, http://www.clinicaltrials.gov.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Chronic rhinitis is a common respiratory disease and can be
categorized broadly as “allergic” and “non-allergic” in origin. Esti-
mated prevalence of allergic rhinitis and non-allergic rhinitis varies
between studies because the etiologies of non-allergic rhinitis are
diverse (e.g., vasomotor rhinitis; non-allergic rhinitis with eosino-
philia; atrophic rhinitis; drug-induced rhinitis; gustatory rhinitis;
occupational rhinitis) but, comparatively, the prevalence of allergic
rhinitis is higher.1,2 In temperate climates, seasonal variation can be
a feature of allergic rhinitis due to ﬂuctuations in pollen exposure.3
In tropical countries, however, symptoms of allergic rhinitis can belinical Immunology, Depart-
linical Immunology Research
ongkram).
ety of Allergology.
rgology. Production and hosting by Elsequite persistent because perennial allergens commonly contrib-
uting to rhinitis symptoms are abundant throughout the year.
Summation of the individual nasal score (sneeze, itchy nose,
rhinorrhea, and blocked nose) or “total nasal symptom score” was
introduced as an endpoint for clinical trials for seasonal allergic
rhinitis and perennial allergic rhinitis.4,5 Most of these data, how-
ever, come from studies in temperate areas.3,6 Few studies have
focused on the presenting symptoms of allergic rhinitis in tropical
regions, where the weather is hot and humid all-year-round.7,8 Due
to persistent exposure to allergens in the tropics, the clinical pat-
terns of allergic rhinitis and non-allergic rhinitis in such a warm
climate may not be distinguishable, and the presenting symptoms
of allergic rhinitis in the tropics may differ from those reported in
temperate climates.
Studies have shown that allergic rhinitis can impair quality of
life (QoL).9 Most reports, however, have relied on the total nasal
symptom score to assess disease severity and treatment. Other
extranasal symptoms frequently overlooked in patients withvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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tients who fail to recognize that their complaints (e.g., breathing
difﬁculties, tiredness) are due to chronic nasal obstruction.10 It has
been shown that patients from Thailand with allergic rhinitis have
impaired QoL compared with healthy control subjects assessed
using the Short Form-36 questionnaire.11 Allergic rhinitis can pre-
sent with various symptoms and is sometimes overlooked. Hence,
identiﬁcation of the common presenting symptoms of allergic
rhinitis and knowing which symptoms impact on general health is
important. Treatment methods targeting these symptoms would
improve the QoL of these patients.
We wished to evaluate the common presenting symptoms of
allergic rhinitis, their impact on QoL, and therapeutic response.Methods
The study protocol was approved by the Ethics and Research
Committee of the Faculty of Medicine, Chulalongkorn University
(Bangkok, Thailand). The study is registered at www.clinicaltrial.
gov (NCT02000648).
Patients aged 18 years visiting allergy clinics within King
Chulalongkorn Memorial Hospital and Chulalongkorn University
Health Service Center in Bangkok and diagnosed with chronic
rhinitis between 2012 and 2014 were recruited. Patients were
requested to complete a clinical record form regarding presenting
symptoms and clinical patterns. Health-related QoL was self-
evaluated using the Optum™ SF-12v2® Health Survey (Thai
version) on the ﬁrst visit before starting treatment. Medications
used and symptom severity after treatment was recorded by pa-
tients at follow-up visits. Patients were asked to rank the severity of
18 symptoms (sneeze, itchy nose, rhinorrhea, blocked nose, post-
nasal drip, itchy eyes, tearing, frequent cough, frequent sore throat,
chronic headache, dry mouth, fatigue, snoring, mouth breathing,
poor sleep, daytime somnolence, and loss of sense of smell) they
might have on a four-point scale (0¼ none, 1¼mild, 2¼moderate,
3 ¼ severe).
Anterior rhinoscopy had been undertaken to exclude anatomic
abnormalities along with measurement of peak nasal inspiratory
ﬂow using In-Check Nasal® (Clement Clarke International, Harlow,
UK). Classiﬁcation of chronic rhinitis was based on Allergic Rhinitis
and its Impact on Asthma guidelines (2010).12 Skin-prick tests with
common aeroallergens in Thailand (mixed dust mites, mixed
cockroaches, mixed molds, cat dander, dog hair, and southern grass
mix; ALK-Abello, Hørsholm, Denmark) were examined. Wheal size
3 mm was considered to denote a positive test.
A total of 344 patients were recruited for skin-prick test on the
ﬁrst visit. According to the results of aeroallergen skin tests, allergic
rhinitis and non-allergic rhinitis were diagnosed in 260 and 84
patients, respectively. Patients with symptoms and signsTable 1
Clinical characteristics of patients with chronic rhinitis who underwent the skin-prick te
All cases with known skin test
result (N ¼ 344)
Male: female (% female) 124:220 (63.95%)
Age (years) 33.19 þ 0.76
Age of onset (years) 24.89 þ 1.12
Persistent rhinitis 272/344 (79.07%)
Total nasal symptom scores 8.13 þ 0.15
Nasal peak inspiratory ﬂow rate (L/min) 134.59 þ 4.70
Associated allergic diseases 57/344 (16.57%)
Concurrent medical illnesses 42/344 (12.21%)
Family history of atopy 126/344 (36.63%)
Patients diagnosed with allergic rhinitis were signiﬁcantly younger, had more severe na
familial atopic history; * represents P < 0.05 and ** represents P < 0.01 comparing the dsuggesting bacterial sinusitis (fever, facial tenderness, or purulent
discharge) were excluded from this study. Correlations between the
ten most common presenting symptoms before treatment and
physical component summary as well as mental component sum-
mary were analyzed using the SF-12v2 Health Survey. Medications
were prescribed based on the allergist's decision in real-life set-
tings. Therapeutic response was evaluated in 55 selected patients
followed-up at 1- and 3-month periods after treatment compared
with baseline symptoms. Each symptom was considered to be
“controlled” if the symptom score was 1.
Statistical analyses
The Student's t-test and chi-square test were used for quanti-
tative and qualitative analyses, respectively. Data were represented
as means ± standard errors. Multinomial logistic regression was
used for multivariate analysis. P < 0.05 was considered signiﬁcant.
Results
Baseline characteristics of patients with allergic rhinitis
A total of 344 chronic rhinitis patients had undergone skin prick
test during the study period. Almost two-thirds were female and
260 patients (75.6%) were conﬁrmed to have an allergy (Table 1).
Positive skin prick tests to mixed dust mites, mixed cockroaches,
mixed molds, cat dander, dog hair, and southern grass mix were
demonstrated in 85.4%, 59.2%, 13.1%, 9.2%, 1.9%, and 7.3% of allergic
rhinitis patients, respectively.
Patients diagnosed with allergic rhinitis were signiﬁcantly
younger and had an earlier age of onset than patients with non-
allergic rhinitis. Total nasal symptom scores at baseline in pa-
tients with allergic rhinitis were higher than those of those with
non-allergic rhinitis, but peak nasal inspiratory ﬂow was compa-
rable. Interestingly, the prevalence of familial atopic history was
signiﬁcantly higher in patients with allergic rhinitis compared with
those with non-allergic rhinitis, but the prevalence of associated
allergic diseases and concurrent medical illnesses between the two
groups was not signiﬁcantly different.
Prevalence and severity of individual symptoms in patients with
allergic rhinitis
Percentages of patients with allergic rhinitis presenting with at
least moderate severity of each symptom were ranked as follows:
blocked nose, 86.8%; rhinorrhea, 80.4%; itchy nose, 76.2%; sneeze,
73.8%; fatigue, 61.2%; postnasal drip, 56.3%; itchy eyes, 54.9%; day-
time somnolence, 54.1%; drymouth, 53.1%;mouth breathing, 51.2%;
chronic headache, 49.4%; poor sleep, 44.6%; sore throat, 39.7%;st.
Allergic (N ¼ 260) Non-allergic (N ¼ 84) P values
91:169 (64.75%) 33:51 (60.71%) 0.28
30.60 þ 0.78 40.31 þ 1.71 <0.01**
22.47 þ 1.17 33.63 þ 2.58 <0.01**
198/260 (76.15%) 74/84 (88.10%) 0.02*
8.50 þ 0.16 6.96 þ 0.32 <0.01**
134.47 þ 5.49 135.00 þ 9.18 0.96
47/260 (18.08%) 10/84 (11.91%) 0.12
28/260 (10.77%) 14/84 (16.67%) 0.11
105/260 (40.38%) 21/84 (25.00%) <0.01**
sal symptoms than patients with non-allergic rhinitis, and had higher prevalence of
ifferences between both groups.
Fig. 1. Presenting symptoms ranked by percentages of patients whose symptom scores
denoted at least moderate severity (N ¼ 260). Four typical nasal symptoms were the
most severe presenting symptoms in allergic rhinitis, followed by fatigue, postnasal
drip, daytime somnolence, itchy eyes, mouth breathing, and dry mouth, respectively.
Fig. 3. Severity of rhinitis symptoms in patients with good quality of life compared
with patients with poor quality of life (N ¼ 260). Data demonstrate that patients with
poor quality of life had more severe symptoms of rhinitis than patients with good
quality of life; * represents P < 0.05 and ** represents P < 0.01 comparing the differ-
ences between both groups.
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smell, 36.0%; tearing, 33.1%; and chronic cough, 25.5%. Only the ﬁrst
top-ten most common presenting symptoms are shown in Figure 1.
Quality of life in patients with allergic rhinitis and correlation with
symptom severity
Physical health and mental health was evaluated using the SF-
12v2 Health Survey (physical health domains comprised physical
functioning, role physical, bodily pain, and general health; mental-
health domains comprised vitality, social functioning, role
emotional, and mental health; Fig. 2). Norm-based scores were
summarized and reported as physical component summary (PCS)
and mental component summary (MCS).
PCS and MCS in patients with allergic rhinitis were 45.7 ± 0.9
and 43.4 ± 1.0, respectively. Based on mean scores, health domains
impaired most in patients with allergic rhinitis were general health
and role emotional. Most symptoms of rhinitis in patients with
poor QoL (PCS or MCS <50) were signiﬁcantly more severe than
those in patients with good QoL (PCS and MCS 50) (Fig. 3).
After adjustment for duration of symptoms, associated allergic
diseases, and underlying medical illnesses, it was demonstrated
that the symptom severity of sneeze was correlated signiﬁcantlyFig. 2. Quality of life in patients with allergic rhinitis assessed using the SF-12v2®
Health Survey (N ¼ 260). Quality of life scores in patients with allergic rhinitis were
lower than those in normal populations, particularly in terms of general health.with PCS alone, whereas severity of postnasal drip and daytime
somnolence were correlated signiﬁcantly with MCS alone. Severity
of dry mouth was correlated signiﬁcantly with both PCS and MCS
(Table 2). Nasal symptom scores (sneeze, itchy nose, rhinorrhea,
and blocked nose) did not signiﬁcantly correlate with the physical
or mental components whereas extranasal symptom scores (post-
nasal drip, itchy eyes, dry mouth, fatigue, mouth breathing, and
daytime somnolence) correlated with the physical and mental
components of QoL.
Therapeutic response of various symptoms in patients with allergic
rhinitis
Fifty-ﬁve patients with allergic rhinitis followed up at 1- and
3-month periods after the ﬁrst visit were assessed for symptom
severity and controlled symptoms. Baseline symptom scores at the
ﬁrst visit revealed that blocked nose, rhinorrhea, sneeze, and itchy
nose were the most severe presenting symptoms in patients with
allergic rhinitis. Daily intranasal corticosteroid alone and combina-
tion therapy with both intranasal corticosteroid and oral antihista-
mine were prescribed in 37.5% and 52.5% of patients, respectively
(data not shown). Symptoms with high scores after 3 months were
blocked nose, postnasal drip, fatigue, and dry mouth (Fig. 4).
Baseline symptoms with the highest uncontrolled symptom
score (2) in patients with allergic rhinitis were blocked nose,
rhinorrhea, sneeze, itchy nose, and fatigue. At 3 months, however,
the proportion of patients with uncontrolled symptoms was 43.9%
for blocked nose, 37.2% for postnasal drip, 33.3% for itchy nose,
31.7% for dry mouth, and 28.6% for fatigue.Discussion
In our cohort, the prevalence of persistent rhinitis in non-
allergic subjects was higher than that in the allergic group. In
Table 2
Correlations between symptom severity and the quality of life in patients with allergic rhinitis.
Rhinitis symptoms Sneeze Itchy
nose
Rhinorrhea Blocked
nose
Postnasal
drip
Itchy
eyes
Dry
mouth
Fatigue Mouth
breathing
Daytime
somnolence
Nasal
symptom
scores
Extranasal
symptom
scores
Total
symptom
scores
Physical
component
summary
Correlation 0.17 0.02 0.14 0.08 0.11 0.03 0.158 0.142 0.097 0.060 0.139 0.152 0.187
P values 0.05* 0.85 0.10 0.35 0.20 0.69 0.07* 0.10 0.26 0.49 0.11 0.08* 0.03*
Mental
component
summary
Correlation 0.08 0.027 0.046 0.020 0.186 0.053 0.251 0.114 0.055 0.151 0.042 0.205 0.183
P values 0.32 0.75 0.60 0.82 0.03* 0.54 0.00** 0.19 0.52 0.08* 0.63 0.02* 0.03*
Correlations between symptom severity and the physical and mental components of quality of life in patients with allergic rhinitis after adjustment of duration of symptoms,
associated allergic diseases, and underlying medical illnesses (N ¼ 260).
*Correlation is signiﬁcant at the 0.05 level (two tailed), **correlation is signiﬁcant at the 0.01 level (two tailed).
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symptoms earlier, and had more severe nasal symptoms compared
with non-allergic subjects. A family history of atopy in patients
diagnosed with allergic rhinitis was also more common. These
clinical characteristics were similar to those from other reports in
temperate countries.6,13
Our study conﬁrmed that the four typical nasal symptoms
(blocked nose, rhinorrhea, sneeze, and running nose) were the
major symptoms in allergic rhinitis for >70% of patients having at
least moderate severity before treatment. Postnasal drip, fatigue,
daytime somnolence, dry mouth, itchy eyes, and mouth breathing
also contributed to the top-ten presenting symptoms in patients
with allergic rhinitis in terms of symptom severity.
Confounding factors such as underlying medical illnesses,
associated allergic diseases, and symptom duration had been
excluded, so allergic rhinitis could affect the general health and
wellbeing of patients. Impairment of physical health and mentalFig. 4. Symptom severity and clinical improvement in patients with allergic rhinitis (N ¼ 5
symptoms at baseline while blocked nose, postnasal drip, fatigue, and dry mouth were thehealth in these patients was correlated signiﬁcantly with severity of
extranasal symptoms, whereas correlation between severity of
sneeze, one of the four main nasal symptoms of rhinitis, and QoL
was observed only in physical-health components. Most symptoms
were improved dramatically within 1 month. Follow-up data
showed that, although typical nasal symptoms of chronic rhinitis
were prominent at baseline, most symptoms could be controlled
readily after treatment except for blocked nose. In contrast, extra-
nasal symptoms such as postnasal drip and dry mouth were less
severe at the beginning but the recalcitrant nature of these symp-
toms would probably lead to impaired QoL in the long term.
At present, the total nasal symptom score is used frequently to
assess the severity of allergic rhinitis and, to lesser extent, non-
allergic rhinitis.14e17 In certain circumstances, calculation of the
total nasal symptom score alone may not be adequate to assess
rhinitis severity. In tropical regions where symptoms of allergic
rhinitis persist throughout the year, extranasal symptoms can be5). Blocked nose, rhinorrhea, sneeze, and itchy nose were the most severe presenting
most recalcitrant symptoms at 3 months after treatment.
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of the total nasal symptom score is not an ideal tool to assess the
severity of allergic rhinitis because these symptoms barely impact
on physical health alone whereas the extranasal or “atypical”
symptoms of chronic rhinitis are closely associated with the
physical and mental components of QoL. Improvement in extra-
nasal symptoms should also be consideredwhen evaluating disease
severity, monitoring therapeutic response in a clinical trial, or
developing new drugs targeting chronic allergic rhinitis.
According to our study, symptoms that were difﬁcult to control
in patients with allergic rhinitis were blocked nose, postnasal drip,
fatigue, and dry mouth. It is well known that chronic rhinitis has a
detrimental effect on sleep.18 Blocked nose is one of the most
bothersome symptoms in persistent rhinitis. In fact, chronic nasal
obstruction has a signiﬁcant impact on sleep quality, daytime
somnolence, fatigue, and QoL.19e21 It is likely that extranasal
symptoms such as dry mouth and mouth breathing were due to
chronic nasal obstruction, especially at nighttime, and thereby
contributed to daytime somnolence and fatigue. Other than
blocked nose, it is worth noting that severity of postnasal drip was
also difﬁcult to control. It is possible that the accessibility of
intranasal steroid spray to the posterior part of the nasal cavity and
pharyngeal wall may be limited, particularly in patients with severe
nasal obstruction and excessive mucus secretion in these areas
could be responsible for persistent postnasal drip symptoms in
these patients. New therapeutic methods targeting chronic nasal
obstruction and its consequences should be considered.
The present study had limitations. Allergic status was diagnosed
based on the skin-prick test alone, and patients with mixed rhinitis
or local allergic rhinitis were not assessed separately. Our study
reﬂected the real-world situation, so the therapeutic response may
be not as good as that observed in clinical trials due to the
compliance issues. Some extranasal symptoms, such as fatigue or
daytime somnolence, may have been secondary to depression.
Whether these symptoms were the consequence of chronic rhinitis
or depressed mood is not known because depression is reported in
about one-quarter of patients with chronic rhinosinusitis, and
chronic psychologic stress can modify the severity of chronic rhi-
nosinusitis.22,23 Use of diagnostic psychologic tests in patients with
allergic rhinitis may help to resolve this problem.
In summary, extranasal symptoms of allergic rhinitis, which are
more difﬁcult to treat than nasal symptoms of allergic rhinitis, can
affect QoL in aspects of physical health and mental health. Better
scoring systems comprising nasal symptoms and extranasal
symptoms should be used to evaluate disease severity, monitor
therapeutic response in clinical trials, or assess the efﬁcacy of drugs
targeting allergic rhinitis.
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